Jefferies Financial Group Inc. decreased its stake in shares of Omada Health, Inc. (NASDAQ:OMDA – Free Report) by 46.7% during the third quarter, HoldingsChannel reports. The firm owned 364,517 shares of the company’s stock after selling 319,574 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Omada Health were worth $7,586,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. China Universal Asset Management Co. Ltd. bought a new stake in Omada Health during the 3rd quarter valued at approximately $70,000. Sterling Capital Management LLC grew its holdings in shares of Omada Health by 1,161.6% during the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock worth $33,000 after acquiring an additional 1,452 shares during the period. Robeco Institutional Asset Management B.V. bought a new position in shares of Omada Health in the 3rd quarter worth approximately $1,100,000. Counterpoint Mutual Funds LLC bought a new position in shares of Omada Health in the 3rd quarter worth approximately $595,000. Finally, State of Alaska Department of Revenue bought a new position in shares of Omada Health in the 3rd quarter worth approximately $59,000.
Analyst Ratings Changes
Several equities research analysts recently weighed in on OMDA shares. Citizens Jmp lifted their price target on Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Friday, August 14th. BTIG Research reissued a “buy” rating and set a $35.00 price objective on shares of Omada Health in a research report on Friday, September 11th. Finally, Wells Fargo & Company dropped their target price on shares of Omada Health from $22.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, November 6th. Eleven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $26.33.
Read Our Latest Research Report on OMDA
Omada Health Stock Down 3.5%
Omada Health stock opened at $14.70 on Friday. The company has a market capitalization of $911.99 million, a P/E ratio of 72.57 and a beta of 2.13. The stock’s 50 day moving average is $19.46 and its 200 day moving average is $17.72. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $25.45.
Omada Health (NASDAQ:OMDA – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.08. Omada Health had a return on equity of 5.71% and a net margin of 4.21%. The company had revenue of $91.31 million for the quarter. As a group, equities analysts expect that Omada Health, Inc. will post 0.09 EPS for the current year.
Insider Activity at Omada Health
In other news, CEO Sean P. Duffy sold 21,572 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $23.62, for a total transaction of $509,530.64. Following the sale, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at $9,728,156.82. This represents a 4.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Wei-Li Shao sold 4,036 shares of the stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $21.85, for a total value of $88,186.60. Following the transaction, the president owned 295,313 shares of the company’s stock, valued at $6,452,589.05. This represents a 1.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 79,322 shares of company stock valued at $1,720,914. Insiders own 6.38% of the company’s stock.
About Omada Health
Omada Health is a U.S. digital health company that provides virtual care programs for people managing chronic conditions. Its services address areas including diabetes, prediabetes, hypertension, musculoskeletal conditions and weight management. The company combines digital tools, personalized health coaching and, where appropriate, clinical support to help members build health habits and manage their care. Programs may include mobile-app-based guidance and connected devices, such as scales or blood pressure monitors.
Featured Stories
- Five stocks we like better than Omada Health
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding OMDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omada Health, Inc. (NASDAQ:OMDA – Free Report).
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
